Northwestern Medicine | Northwestern University | Faculty Profiles
News Center
A new class of experimental drug-like small molecules is showing great promise in targeting a brain enzyme to prevent early memory loss in Alzheimer’s disease.
Alzheimer’s drug may act like bad electrician, messing up wiring in brain and nervous system.